4LLW
Crystal structure of Pertuzumab Clambda Fab with variable domain redesign (VRD2) at 1.95A
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 31-ID |
Synchrotron site | APS |
Beamline | 31-ID |
Temperature [K] | 77 |
Detector technology | CCD |
Collection date | 2013-02-01 |
Detector | RAYONIX MX225HE |
Wavelength(s) | .97931 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 85.596, 71.179, 90.924 |
Unit cell angles | 90.00, 99.28, 90.00 |
Refinement procedure
Resolution | 35.320 - 1.950 |
R-factor | 0.212 |
Rwork | 0.209 |
R-free | 0.26190 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.011 |
RMSD bond angle | 1.510 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | REFMAC |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 35.320 | 2.060 |
High resolution limit [Å] | 1.950 | 1.950 |
Rmerge | 0.113 | 0.719 |
Number of reflections | 76929 | |
Completeness [%] | 97.9 | 97.2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.2 | 294 | 15% PEG 8K + 200mM Ammonium Sulfate , pH 7.2, VAPOR DIFFUSION, SITTING DROP, temperature 294K |